Cargando…
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
BACKGROUND: Every year, an estimated one million children and young adolescents become ill with tuberculosis, and around 226,000 of those children die. Xpert MTB/RIF Ultra (Xpert Ultra) is a molecular World Health Organization (WHO)‐recommended rapid diagnostic test that simultaneously detects Mycob...
Autores principales: | Kay, Alexander W, Ness, Tara, Verkuijl, Sabine E, Viney, Kerri, Brands, Annemieke, Masini, Tiziana, González Fernández, Lucia, Eisenhut, Michael, Detjen, Anne K, Mandalakas, Anna M, Steingart, Karen R, Takwoingi, Yemisi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446385/ https://www.ncbi.nlm.nih.gov/pubmed/36065889 http://dx.doi.org/10.1002/14651858.CD013359.pub3 |
Ejemplares similares
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019) -
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021) -
Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018) -
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)